Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$514.65 +12.70 (+2.53%)
At close: Oct 20, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Non-Current Debt (2009 - 2018)

Updated

Vertex Pharmaceuticals (VRTX) recorded Non-Current Debt of -$140,000 in Q4 2014.

Analysis

Vertex Pharmaceuticals (VRTX) Non-Current Debt (2009 - 2018) Analysis & Trends

For FY2014, Vertex Pharmaceuticals reported Non-Current Debt of $294.24 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 37.34 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 62.48 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 23.83 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 60.50 Bn
10 Vertex Pharmaceuticals 130.00 Bn 102.01 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 561.89 Mn
Sep 30, 2018 561.39 Mn
Jun 30, 2018 562.65 Mn
Mar 31, 2018 561.30 Mn
Dec 31, 2017 563.41 Mn
Sep 30, 2017 547.05 Mn
Jun 30, 2017 525.02 Mn
Mar 31, 2017 498.78 Mn
Dec 31, 2016 486.36 Mn
Sep 30, 2016 473.07 Mn
Jun 30, 2016 472.37 Mn
Mar 31, 2016 472.49 Mn
Dec 31, 2015 472.61 Mn
Sep 30, 2015 472.72 Mn
Jun 30, 2015 472.83 Mn
Mar 31, 2015 472.97 Mn
Dec 31, 2014 473.07 Mn
Sep 30, 2014 473.17 Mn
Jun 30, 2014 473.27 Mn
Mar 31, 2014 473.36 Mn
API Access

Vertex Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=VRTX&period=max&api_key=YOUR_API_KEY